Marco Bocchetti
Overview
Explore the profile of Marco Bocchetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Mauro A, Santorsola M, Savarese G, Sirica R, Ianniello M, Cossu A, et al.
J Transl Med
. 2025 Jan;
23(1):28.
PMID: 39780166
No abstract available.
2.
Ottaiano A, Santorsola M, Sirica R, Di Mauro A, Di Carlo A, Ianniello M, et al.
Neoplasia
. 2024 Dec;
60:101111.
PMID: 39709701
Background: Oligo-metastatic disease (OMD) in colon cancer patients exhibits distinct clinical behavior compared to poly-metastatic disease (PMD), with a more responsive and indolent course. This study aims to identify clinical...
3.
Di Mauro A, Santorsola M, Savarese G, Sirica R, Ianniello M, Cossu A, et al.
J Transl Med
. 2024 Dec;
22(1):1107.
PMID: 39639373
Background: Microsatellite instability (MSI) is a well-established predictive biomarker for immune checkpoint inhibitor (ICI) response in metastatic colon cancer. Both high MSI and tumor mutational burden (TMB) are markers of...
4.
Motta G, Brandolini B, Di Meglio T, Allosso S, Mesolella M, Ricciardiello F, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597917
Background: The incidence of patients showing neck metastasis and no obvious primary tumor at the initial diagnostic evaluation or neck cancer of unknown primary (NCUP) is rising. It is estimated...
5.
Abate M, Porru M, Campani V, Leonetti C, Nele V, Di Paola R, et al.
J Control Release
. 2024 Nov;
377:458-469.
PMID: 39577464
Glioblastoma (GBM) is a highly aggressive brain cancer with poor clinical outcome. Unfortunately, chemotherapy with temozolomide (TMZ) has a limited efficacy due to resistance mainly attributed to O6-methylguanine methyl transferase...
6.
Bocchetti M, Misso G, Zappavigna S, Scrima M, Caraglia M, Pentimalli F, et al.
World J Gastrointest Surg
. 2024 Oct;
16(9):2774-2777.
PMID: 39351545
The recently published study by Duan introduces a promising method that combines genomic instability and long non-coding RNAs to improve the prognostic evaluation of hepatocellular carcinoma (HCC), a deadly cancer...
7.
Bocchetti M, Luce A, Iannarone C, Pasquale L, Falco M, Tammaro C, et al.
J Transl Med
. 2024 Jun;
22(1):582.
PMID: 38902710
Background: Exosomes are nanosized vesicles released from all cells into surrounding biofluids, including cancer cells, and represent a very promising direction in terms of minimally invasive approaches to early disease...
8.
Ricciardiello F, Falco M, Scarpa A, Motta G, Viola P, Bocchetti M, et al.
Eur Arch Otorhinolaryngol
. 2024 May;
281(9):5015-5020.
PMID: 38771342
Objective: To explore the potential role of miR-449a as biomarker for laryngeal squamous cell carcinoma (LSCC), especially in the decision strategy of neck dissection (ND). Methods: Each patient underwent total...
9.
Tathode M, Bonomo M, Zappavigna S, Mang S, Bocchetti M, Camele I, et al.
Front Microbiol
. 2024 Apr;
15:1268216.
PMID: 38638895
Introduction: Many lactic acid bacteria (LAB) strains are currently gaining attention in the food industry and various biological applications because of their harmless and functional properties. Given the growing consumer...
10.
Cossu A, Melisi F, Noviello T, Pasquale L, Grisolia P, Reale C, et al.
Mol Ther Nucleic Acids
. 2024 Mar;
35(1):102140.
PMID: 38425711
MicroRNAs (miRNAs) are involved in post-transcriptional gene expression regulation and in mechanisms of cancer growth and metastases. In this light, miRNAs could be promising therapeutic targets and biomarkers in clinical...